Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125929691 | 12592969 | 1 | I | 201510 | 20151103 | 20160726 | 20160726 | PER | US-ABBVIE-15P-163-1493414-00 | ABBVIE | 69.42 | YR | F | Y | 68.10000 | KG | 20160726 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125929691 | 12592969 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 1039327 | 21402 | 75 | UG | TABLET | QD | ||||||
| 125929691 | 12592969 | 2 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 1039327 | 21402 | 75 | MG | TABLET | |||||||
| 125929691 | 12592969 | 3 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125929691 | 12592969 | 1 | Hypothyroidism |
| 125929691 | 12592969 | 3 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125929691 | 12592969 | Chest discomfort | |
| 125929691 | 12592969 | Oxygen saturation decreased | |
| 125929691 | 12592969 | Product packaging issue | |
| 125929691 | 12592969 | Product quality issue | |
| 125929691 | 12592969 | Ventricular extrasystoles |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |